Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread

Part of paid clinical trials in Princeton, New Jersey.

Sponsor
Bristol-Myers Squibb
Study ID
NCT03165409
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This study is a real-world retrospective claims analysis to assess and compare AE-related HCRU and medical costs among patients with different follow-up frequency after initiating a melanoma therapy.

Key Dates

Start date
Feb 27, 2017
Status verified
Oct 2017
Primary completion
Sep 30, 2017
Completion
Sep 30, 2017

Study Design

Enrollment
1,828 participants (actual)

Primary Outcome Measure

Composite monthly incidence rate of adverse events (AEs), AE-related healthcare resource utilization, and medical costs among the metastatic melanoma patients with less frequent general outpatient visits [ Time Frame: Approximately 5 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Bristol-Myers SquibbPrincetonNew Jersey08540-

Find similar trials in Princeton, NJ

By condition
Melanoma
By specialty
OncologySkin cancerDermatology
By research site
Bristol-Myers Squibb· Princeton, NJ

Related Studies